GSK picks up pulmonary hypertension drug with 35Pharma acquisition The drugmaker has been investing in respiratory medicine as it faces aggressive revenue targets

https://www.statnews.com/2026/02/25/gsk-acquires-35pharma-pulmonary-hypertension/ By Andrew JosephFeb. 25, 2026 Europe Correspondent